Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Baxter International to acquire Claris Injectables Limited for $625 Million
Friday, December 16, 2016Baxter International Inc a global leader in sterile medication production and delivery today entered into a definitive agreement to acquire Claris Injectables Limited a wholly owned subsidiary of Claris Lifesciences Limited for total consideration of...
Evotec and Celgene enter into drug discovery collaboration for neurodegenerative diseases
Friday, December 16, 2016Evotec AG announced that Evotec and Celgene Corporation have entered into a strategic drug discovery and development collaboration to identify diseasemodifying therapeutics for a broad range of neurodegenerative diseases Initial disease areas of focu...
IntelGenx and RedHill Biopharma Signed License Agreement with Pharmatronic Co.
Thursday, December 15, 2016IntelGenx Corp and RedHill Biopharma Ltd announced the signing of an exclusive license agreement with Pharmatronic Co Pharmatronic Co for the commercialization of RIZAPORT in the Republic of Korea South Korea RIZAPORT is a proprietary oral thin film...
CFDA Granted Approval for Phase I/II/III Clinical Trials of Sihuan Pharmaceutical’s Fadanafil Drug
Thursday, December 15, 2016Sihuan Pharmaceutical Holdings Group Ltd a leading pharmaceutical company with the largest cardiocerebral vascular drug franchise in Chinas prescription market announced that the China Food and Drug Administration CFDA has granted approval of Phase I...
Ab Initio Announces Collaboration Agreement with Pfizer to Discover GPCR Activating Antibodies
Wednesday, December 14, 2016Ab Initio Biotherapeutics Inc today announced a collaborative research and license agreement with Pfizer Inc NYSE PFE that aims to discover novel therapeutic antibodies against an undisclosed target in the Gprotein coupled receptor GPCR superfamily G...
Medicure announces filing of ANDA in collaboration with Apicore
Wednesday, December 14, 2016Medicure Inc a leading Canadian specialty pharmaceutical company is pleased to announce that an abbreviated New Drug Application ANDA was filed with the US Food and Drug Administration for a highvalue cardiovascular generic drug developed as a collab...
Sage Therapeutics Announces Initiation of Phase 2 Clinical Development for SAGE-217 in Movement Disorders
Wednesday, December 14, 2016Sage Therapeutics a clinicalstage biopharmaceutical company developing novel medicines to treat lifealtering central nervous system CNS disorders today announced the initiation of Phase clinical development of SAGE a novel internallydeveloped next g...
Sun Pharma & Moebius Medical sign exclusive global licensing deal to develop MM-II
Tuesday, December 13, 2016Sun Pharma and Israelbased Moebius Medical have entered into an exclusive worldwide licensing deal to further develop MMII a novel pharmaceutical candidate for the treatment of pain in osteoarthritis MMII is a novel nonopioid product that leverages t...
Astellas Pharma to Transfer the exclusive rights for Qutenza to Grünenthal
Tuesday, December 13, 2016Astellas Pharma Inc President and CEO Yoshihiko Hatanaka Astellas today announced that Astellas Pharma Europe Ltd Astellas Pharma Europe has entered into a definitive agreement with Grnenthal under which Astellas Pharma Europe will transfer the exclu...
Sunshine Biopharma Signs Strategic Alliance Agreement With Atlas Pharma
Monday, December 12, 2016Sunshine Biopharma Inc a fully integrated pharmaceutical company offering generic and proprietary drugs for the treatment of cancer and other acute and chronic indications is pleased to announce that it has signed a Strategic Alliance Agreement with...
